Published Date: 19 Feb 2025
A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, ...
Read Full NewsA phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.
Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.
Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.
A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.
Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.
Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.
Research is limited, but what has been done shows a possible connection.
1.
'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
2.
Skinny melanoma incidence is associated with vitamin D deficiency.
3.
Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.
4.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
5.
The Kansas Cancer Center awarded two Indian American doctors professorships.
1.
Understanding Epidural Hematoma: Symptoms, Causes and Treatment
2.
Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment
3.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
4.
What Is A High MCV Level? Causes, Symptoms, And Treatment Options
5.
Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part I
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Navigating the Complexities of Ph Negative ALL - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation